Figures & data
Table 1 Patient demographics of the safety population
Figure 1 Decrease in diurnal IOP from baseline produced by travoprost and tafluprost. (intent-to-treat population, N = 48).
Abbreviation: IOP, intraocular pressure.
![Figure 1 Decrease in diurnal IOP from baseline produced by travoprost and tafluprost. (intent-to-treat population, N = 48).](/cms/asset/d344cd36-33fe-43c7-b405-6ac353d6860b/doph_a_13720_f0001_b.jpg)
Table 2 Mean intraocular pressure at baseline and after six weeks of therapy with travoprost and tafluprost (intent-to-treat population, N = 48)
Table 3 Mean change from baseline on the symptom survey scores (based on a scale of 0–4) after six weeks of therapy with travoprost and tafluprost (intent-to-treat population, N = 48)